You have 9 free searches left this month | for more free features.

Yervoy

Showing 26 - 50 of 376

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Nivolumab, Ipilimumab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Sep 7, 2022

Pancreatic Cancer Trial in Baltimore (Tadalafil, Pembrolizumab, Ipilimumab)

Recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 23, 2022

Breast Tumor Female, Breast Cancer, Breast Carcinoma Trial in Portland (Nivolumab, Ipilimumab, Bicalutamide)

Recruiting
  • Breast Neoplasm Female
  • +3 more
  • New York, New York
  • +1 more
Dec 21, 2022

Prostate Cancer Metastatic, Castrate Resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Herlev

Recruiting
  • Prostate Cancer Metastatic
  • +3 more
  • Stereotactic body radiotherapy
  • +3 more
  • Herlev, Capital Region, Denmark
    Department of Oncology, Copenhagen University Hospital Herlev an
Dec 16, 2022

Melanoma Trial in Washington, Baltimore, Hackensack (Nivolumab, Ipilimumab, Cabozantinib)

Suspended
  • Melanoma
  • Washington, District of Columbia
  • +2 more
Jan 18, 2023

Melanoma, Brain Metastases Trial in Spain (Ipilimumab)

Completed
  • Melanoma
  • Brain Metastases
  • Badalona, Spain
  • +11 more
Oct 10, 2022

Metastatic Cancer Trial in Rochester (Keytruda Injectable Product, Yervoy Injectable Product, Cytoxan)

Recruiting
  • Metastatic Cancer
  • Keytruda Injectable Product
  • +4 more
  • Rochester, Michigan
    Ascension Providence Rochester Hospital
Jun 15, 2022

Metastatic Melanoma, Metastasis to Brain Trial in Tampa, Houston (Nivolumab, Ipilimumab, Nivolumab + Relatlimab)

Recruiting
  • Metastatic Melanoma
  • Metastasis to Brain
  • Tampa, Florida
  • +1 more
Jan 30, 2023

Metastatic Soft-tissue Sarcoma Trial in United States (Cabozantinib, Nivolumab, Ipilimumab)

Recruiting
  • Metastatic Soft-tissue Sarcoma
  • Stanford, California
  • +3 more
Jan 10, 2023

Active, not recruiting
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • +8 more
  • Cetuximab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute (UPCI)
Jan 26, 2023

NSCLC Stage IV, HIV, HBV Trial in Verona (Nivolumab and Ipilimumab)

Not yet recruiting
  • NSCLC Stage IV
  • +4 more
  • Nivolumab and Ipilimumab
  • Verona, Veneto/Verona, Italy
    Centro Ricerche Cliniche
Oct 26, 2022

Pancreatic Cancer Trial in Herlev (drug, biological, radiation)

Recruiting
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev and Gentofte Hospital
Mar 15, 2022

Merkel Cell Carcinoma, Skin Cancer Trial in Tampa, Columbus (Nivolumab, Ipilimumab, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Merkel Cell Carcinoma
  • Skin Cancer
  • Tampa, Florida
  • +1 more
Nov 11, 2022

Metastatic Prostatic Adenocarcinoma Trial in Lancaster, Rochester (Opdivo Injectable Product, Yervoy Injectable Product,

Completed
  • Metastatic Prostatic Adenocarcinoma
  • Opdivo Injectable Product
  • +3 more
  • Lancaster, California
  • +1 more
Jun 15, 2022

Colorectal Tumors Malignant, Liver Metastases Trial in Ramat Gan (Liver radiation therapy, Nivolumab Injection [Opdivo],

Active, not recruiting
  • Colorectal Neoplasms Malignant
  • Liver Metastases
  • Liver radiation therapy
  • +3 more
  • Ramat Gan, Israel
    Sheba Medical Center
May 20, 2022

Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

Recruiting
  • Colon Carcinoma
  • Amsterdam, Netherlands
  • +5 more
Jan 23, 2023

Urothelial Carcinoma, Bladder Cancer Trial in Rotterdam, Utrecht (Ipilimumab + nivolumab)

Active, not recruiting
  • Urothelial Carcinoma
  • Bladder Cancer
  • Ipilimumab + nivolumab
  • Rotterdam, Netherlands
  • +1 more
Apr 14, 2022

Non-small Cell Lung Carcinoma Trial (Pembrolizumab, Paclitaxel, Carboplatin)

Completed
  • Non-small Cell Lung Carcinoma
  • Pembrolizumab
  • +7 more
  • (no location specified)
Oct 13, 2022

Renal Cell Carcinoma Trial in Houston (Ipilimumab, Nivolumab, Ciforadenant)

Not yet recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Pancreatic Cancer Trial in Herlev (Nivolumab, Ipilimumab, Tocilizumab)

Terminated
  • Pancreatic Cancer
  • Herlev, Denmark
    Herlev & Gentofte University Hospital, Denmark
Mar 15, 2022

Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

Recruiting
  • Breast Cancer
  • Los Angeles, California
  • +2 more
Sep 27, 2022

Kidney Cancer Trial in Boston (NeoVax, Ipilimumab)

Recruiting
  • Kidney Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Houston (SD-101, Pembrolizumab, Nivolumab)

Recruiting
  • Hepatocellular Carcinoma
  • Intrahepatic Cholangiocarcinoma
  • New York, New York
  • +3 more
Oct 19, 2022